![N-(1-Oxopentyl)-N-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-L-valine phenylmethyl ester](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fcas-image%2Fthumb-webp%2F306099-n-1-oxopentyl-n-2-2h-tetrazol-5-yl-11-biphenyl-4-yl-methyl-l-valine-phenylmethyl-ester.webp&w=3840&q=75)
CAS 137863-20-8
:N-(1-Oxopentyl)-N-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-L-valine phenylmethyl ester
Description:
N-(1-Oxopentyl)-N-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-L-valine phenylmethyl ester, with CAS number 137863-20-8, is a synthetic compound characterized by its complex structure, which includes a valine amino acid derivative, a phenylmethyl ester group, and a tetrazole moiety. This compound is likely to exhibit properties typical of peptide-like substances, including potential biological activity due to the presence of the amino acid and the tetrazole ring, which can enhance solubility and bioavailability. The presence of the biphenyl group may contribute to its hydrophobic characteristics, influencing its interaction with biological membranes. Additionally, the oxopentyl group may play a role in the compound's reactivity and stability. Such compounds are often studied for their potential applications in pharmaceuticals, particularly in drug design and development, due to their ability to mimic natural biological molecules. However, specific characteristics such as solubility, melting point, and biological activity would require empirical data for precise evaluation.
Formula:C31H35N5O3
InChI:InChI=1S/C31H35N5O3/c1-4-5-15-28(37)36(29(22(2)3)31(38)39-21-24-11-7-6-8-12-24)20-23-16-18-25(19-17-23)26-13-9-10-14-27(26)30-32-34-35-33-30/h6-14,16-19,22,29H,4-5,15,20-21H2,1-3H3,(H,32,33,34,35)/t29-/m0/s1
InChI key:InChIKey=VXKKFWDUSKMRNO-LJAQVGFWSA-N
SMILES:C(N([C@H](C(OCC1=CC=CC=C1)=O)[C@@H](C)C)C(CCCC)=O)C2=CC=C(C3=C(C=CC=C3)C=4NN=NN4)C=C2
Synonyms:- (S)-Benzyl 2-(N-((2′-(1H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoate
- <span class="text-smallcaps">L</span>-Valine, N-(1-oxopentyl)-N-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-, phenylmethyl ester
- <span class="text-smallcaps">L</span>-Valine, N-(1-oxopentyl)-N-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-, phenylmethyl ester
- N-(1-Oxopentyl)-N-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-<span class="text-smallcaps">L</span>-valine phenylmethyl ester
- Valsartan Benzyl Ester
- benzyl N-pentanoyl-N-{[2'-(2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valinate
- L-Valine, N-(1-oxopentyl)-N-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-, phenylmethyl ester
- L-Valine, N-(1-oxopentyl)-N-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-, phenylmethyl ester
- N-(1-Oxopentyl)-N-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-L-valine phenylmethyl ester
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 8 products.
Valsartan Related Compound C (N-Valeryl-N-{[2'-(1H-tetrazole-5-yl)biphenyl-4-yl]methyl}-L-valine benzyl ester)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C31H35N5O3Color and Shape:White PowderMolecular weight:525.27399L-Valine, N-(1-oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, phenylmethyl ester
CAS:Formula:C31H35N5O3Purity:98%Color and Shape:SolidMolecular weight:525.6413Valsartan EP Impurity B (Valsartan USP Related Compound C)
CAS:Formula:C31H35N5O3Color and Shape:White To Off-White SolidMolecular weight:525.65Benzyl (2S)-3-Methyl-2-[pentanoyl[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]amino]butanoate
CAS:Color and Shape:NeatValsartan Benzyl Ester
CAS:Impurity Valsartan USP Related Compound C
Applications Valsartan (V095750) intermediate. Valsartan USP Related Compound C.
References Cramer., et al.: J. Med. Chem., 42, 3919 (1999),Formula:C31H35N5O3Color and Shape:NeatMolecular weight:525.64N-(1-Oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]
CAS:Poloxamer 407 is a synthetic, non-biodegradable polymer that is used as a surfactant in pharmaceutical preparations. It is typically used to solubilize poorly water-soluble drugs. Poloxamer 407 has been shown to inhibit angiotensin II type 1 receptor blockers and hydrochloric acid, which are involved in the production of stomach acid and regulate blood pressure. The chloride ions present in this polymer are also responsible for its antibacterial properties. It has been shown to be effective against bacteria such as Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus. This polymer can also be used as an active targeting agent for drug delivery systems by attaching it to other molecules with specific biological activities. Poloxamer 407 is soluble in organic solvents that are commonly found in the environment such as halides (e.g., chloride). This polymer also hydrolyzes under basic conditions into potassium ionFormula:C31H35N5O3Purity:Min. 95%Color and Shape:White PowderMolecular weight:525.64 g/molValsartan benzyl ester
CAS:Valsartan benzyl ester is a intermediate of Valsartan.Formula:C31H35N5O3Purity:98%Color and Shape:SolidMolecular weight:525.64
![L-Valine, N-(1-oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, phenylmethyl est…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb%2FDA0013ZY.jpg&w=3840&q=75)
![Benzyl (2S)-3-Methyl-2-[pentanoyl[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]amino]butanoate](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F86%2Fthumb%2FMM0487.03-0025.jpg&w=3840&q=75)
![N-(1-Oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb%2FIO28663.jpg&w=3840&q=75)
